Business Context and Reporting Period
Company: AMERISAFE, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: July 24, 2025
Event: Reauthorization of a share repurchase program.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial figure disclosed relates to capital allocation:
- Share Repurchase Authorization: $25.0 million available for future repurchases of common stock.
Material Changes
The Board of Directors reauthorized a $25.0 million share repurchase program, replacing the prior program. The new program has no expiration date. As of July 24, 2025, the full $25.0 million is available for use.
Guidance, Outlook, and Management Commentary
- Funding Source: Future repurchases are anticipated to be funded from available capital.
- Flexibility: The program does not obligate the Company to repurchase any shares. It may be modified, increased, suspended, or terminated at the Board's discretion based on market conditions and regulatory considerations.
- Execution: Repurchases may be executed pursuant to Rule 10b5-1 trading plans.
Investor Verification Checklist
- Verify the exact terms of the new $25.0 million repurchase authorization in the attached press release (Exhibit 99.1).
- Confirm the Company's current cash position and liquidity status in the most recent 10-Q or 10-K to assess the feasibility of funding the repurchases from "available capital."
- Monitor future filings for actual repurchase activity and any changes to the program status.